Wegovy 0.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6SE1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,232
Award facts
- Contract value 100% obligated
- $11,232.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,232.09 to AmerisourceBergen Drug Corp for the supply of Wegovy 0.5 mg/0.5 ml pen injections. The award was made on January 12, 2026, with an ultimate completion date of January 13, 2026, and is structured as a firm fixed-price contract with no set-aside designation. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company has demonstrated extensive capability in fulfilling federal pharmaceutical supply requirements through its portfolio of competitively awarded contracts with the Defense Logistics Agency and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The underlying IDC encompasses a broad spectrum of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, positioning AmerisourceBergen as a key supplier for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F6SE1?
SPE2DR26F6SE1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F6SE1 worth?
The government has obligated $11,232 on SPE2DR26F6SE1.
Is contract SPE2DR26F6SE1 an order under another contract?
Yes. SPE2DR26F6SE1 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SE1 competed?
The extent of competition for SPE2DR26F6SE1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award